CUE - Cue Biopharma, Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2019
31/12/2018
31/12/2017
31/12/2016
Total revenue
3,988
3,458
1,143
0
0
Operating expenses
Research development
29,040
27,487
28,544
18,900
5,688
Selling general and administrative
13,285
12,740
11,295
4,334
1,970
Total operating expenses
42,326
40,228
39,839
23,234
7,658
Operating income or loss
-38,337
-36,769
-38,697
-23,234
-7,658
Total other income/expenses net
-7.922
64.078
165.337
-
-
Income before tax
-37,837
-36,286
-38,155
-23,234
-7,658
Income tax expense
-
412.5
825
-
-
Income from continuing operations
-38,250
-36,699
-38,980
-23,234
-7,658
Net income
-38,250
-36,699
-38,980
-23,234
-7,658
Net income available to common shareholders
-38,250
-36,699
-38,980
-23,234
-7,658
Basic EPS
-
-1.66
-1.94
-1.13
-0.37
Diluted EPS
-
-1.66
-1.94
-1.13
-0.37
Basic average shares
-
22,042
20,134
20,641
20,641
Diluted average shares
-
22,042
20,134
20,641
20,641
EBITDA
-
-31,604
-37,937
-22,814
-7,456